Rep. Pramila Jayapal, D-Wash., said the White House is supportive of proposals for sweeping Medicare expansion that would broaden coverage and lower the eligibility age to 60, but only if lawmakers ...

(Reuters) — Eli Lilly and Novo Nordisk are expected to announce deals with the Trump administration to cut prices of their weight-loss drugs in exchange for Medicare coverage, a White House source ...

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

(Reuters) -Eli Lilly and Novo Nordisk are expected to announce deals with the White House to offer the lowest dose of their weight-loss drugs at $149 per month, in exchange for Medicare coverage, ...

Novo Nordisk’s Ozempic, Astellas’ Xtandi and Pfizer’s Ibrance are among the 15 drugs that have a new fair maximum price.

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump admin touts Medicare drug savings ...

Trump prepares a health care plan proposing an ACA subsidy extension, new eligibility caps and measures to counter premium spikes as year-end deadlines approach.

The United Kingdom agreed to pay more for prescription drugs in a trade deal announced with the U.S. on Monday that will ...